Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
HIV/ Hepatitic C co infected with documented HCV viremia evidence for cirrhosis and or hepatic fibrosis on liver biopsy, positive fibrosis index, stable health
You may not be if
Decompensated cirrhosis (Child Pugh B or C)
Pregnant or lactating women
History of previous antiretrovirals \> 14 days
Clareo Health | An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C
